Works by Viksna, Anda

Results: 8

Unraveling tuberculosis patient cluster transmission chains: integrating WGS-based network with clinical and epidemiological insights.

Published in:

Frontiers in Public Health, 2024, p. 1, doi. 10.3389/fpubh.2024.1378426

By:

Sadovska, Darja;
Ozere, Iveta;
Pole, Ilva;
Ķimsis, Jānis;
Vaivode, Annija;
Vīksna, Anda;
Norvaiša, Inga;
Bogdanova, Ineta;
Ulanova, Viktorija;
Čapligina, Valentīna;
Bandere, Dace;
Ranka, Renāte

Publication type:

Article

Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic Perspective.

Published in:

Pharmaceutics, 2024, v. 16, n. 3, p. 388, doi. 10.3390/pharmaceutics16030388

By:

Kivrane, Agnija;
Ulanova, Viktorija;
Grinberga, Solveiga;
Sevostjanovs, Eduards;
Viksna, Anda;
Ozere, Iveta;
Bogdanova, Ineta;
Zolovs, Maksims;
Ranka, Renate

Publication type:

Article

Discordance Between Phenotypic and WGS-Based Drug Susceptibility Testing Results for Some Anti-Tuberculosis Drugs: A Snapshot Study of Paired Mycobacterium tuberculosis Isolates with Small Genetic Distance.

Published in:

Infection & Drug Resistance, 2024, v. 17, p. 3289, doi. 10.2147/IDR.S468997

By:

Sadovska, Darja;
Nodieva, Anda;
Pole, Ilva;
Vīksna, Anda;
Ķimsis, Jānis;
Ozere, Iveta;
Norvaiša, Inga;
Bogdanova, Ineta;
Bandere, Dace;
Ranka, Renāte

Publication type:

Article

Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.

Published in:

BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08629-7

By:

Vīksna, Anda;
Sadovska, Darja;
Berge, Iveta;
Bogdanova, Ineta;
Vaivode, Annija;
Freimane, Lauma;
Norvaiša, Inga;
Ozere, Iveta;
Ranka, Renāte

Publication type:

Article

Identification of Factors Determining Patterns of Serum C-Reactive Protein Level Reduction in Response to Treatment Initiation in Patients with Drug-Susceptible Pulmonary Tuberculosis.

Published in:

Antibiotics (2079-6382), 2024, v. 13, n. 12, p. 1216, doi. 10.3390/antibiotics13121216

By:

Kivrane, Agnija;
Ulanova, Viktorija;
Grinberga, Solveiga;
Sevostjanovs, Eduards;
Viksna, Anda;
Ozere, Iveta;
Bogdanova, Ineta;
Simanovica, Ilze;
Norvaisa, Inga;
Pahirko, Leonora;
Bandere, Dace;
Ranka, Renate

Publication type:

Article

Prolonged Corticosteroid Use in the Treatment of Tuberculous Meningoencephalitis: A Case Report.

Published in:

Medicina (1010660X), 2025, v. 61, n. 2, p. 214, doi. 10.3390/medicina61020214

By:

Holstroma, Annija;
Balodis, Arturs;
Brokans, Artis;
Viksna, Anda

Publication type:

Article

Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1332752

By:

Ulanova, Viktorija;
Kivrane, Agnija;
Viksna, Anda;
Pahirko, Leonora;
Freimane, Lauma;
Sadovska, Darja;
Ozere, Iveta;
Cirule, Andra;
Sevostjanovs, Eduards;
Grinberga, Solveiga;
Bandere, Dace;
Ranka, Renate

Publication type:

Article

Next-Generation Sequencing and Bioinformatics-Based Protocol for the Full-Length CYP2E1 Gene Polymorphism Analysis.

Published in:

Pharmacogenomics & Personalized Medicine, 2022, v. 15, p. 959, doi. 10.2147/PGPM.S371709

By:

Igumnova, Viktorija;
Kivrane, Agnija;
Viksna, Anda;
Norvaisa, Inga;
Ranka, Renate

Publication type:

Article